about
Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's diseaseFerritin for the clinicianClick Chemistry-Mediated Nanosensors for Biochemical AssaysCharting the travels of copper in eukaryotes from yeast to mammalsThe molecular basis of memory. Part 2: chemistry of the tripartite mechanismTransferrin Receptor Controls AMPA Receptor Trafficking Efficiency and Synaptic PlasticityCtr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domainChemical tools for detecting Fe ionsMaternofetal and neonatal copper requirements revealed by enterocyte-specific deletion of the Menkes disease protein.Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder.The role of iron in brain ageing and neurodegenerative disorders.Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.The interactome of the copper transporter ATP7A belongs to a network of neurodevelopmental and neurodegeneration factors.Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes.Toward the development of prochelators as fluorescent probes of copper-mediated oxidative stress.Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.A prochelator activated by hydrogen peroxide prevents metal-induced amyloid Beta aggregation.Redox control of prion and disease pathogenesis.Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesionsFluorescent sensors for measuring metal ions in living systemsGenetic determinants of amidating enzyme activity and its relationship with metal cofactors in human serumCardiac copper deficiency activates a systemic signaling mechanism that communicates with the copper acquisition and storage organs.Toward the detection of cellular copper(II) by a light-activated fluorescence increaseCombined zebrafish-yeast chemical-genetic screens reveal gene-copper-nutrition interactions that modulate melanocyte pigmentation.The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy.Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system.Oxidative stress in schizophrenia: an integrated approach.Mechanisms for copper acquisition, distribution and regulation.Systemic and cerebral iron homeostasis in ferritin knock-out mice.Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy.Ferritin overexpression in Drosophila glia leads to iron deposition in the optic lobes and late-onset behavioral defects.Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells.Activation and regulation of purinergic P2X receptor channelsAceruloplasminaemia: a rare but important cause of iron overload.Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.Optimizing production of Fc-amidated peptides by Chinese hamster ovary cellsGenetic polymorphism of the iron-regulatory protein-1 and -2 genes in age-related macular degeneration.Airborne copper exposure in school environments associated with poorer motor performance and altered basal ganglia.Mechanistic analysis of iron accumulation by endothelial cells of the BBBIron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillation.
P2860
Q24293110-A27A8F8C-9031-4DEF-8795-7BC2DF270DE2Q24642942-462327BA-C559-4001-B7CD-1A95D33658E6Q26746175-49491EC5-61CD-4E7D-891D-EB6ED8284D7FQ26863502-192F23DC-9674-44E7-9E08-E5A5279D4827Q26998797-14F35BFE-3A79-4A14-BBB8-0F23FA2926D0Q27349241-A7B22502-65B8-4E64-BE85-2AC3077937C3Q28589065-E64966F9-E0B4-424B-B9CD-CF08540D0342Q28817879-568E6C12-58E8-475A-A428-7686B90940A7Q30530787-D350EC35-7066-4B8C-8FE4-1ADC7656971CQ30540080-72006519-BAE0-4AF4-BBDE-9E920D65160AQ30852753-BA1A9F6E-17CE-4549-8FDE-71B34B6AFB9CQ33320694-205D9708-1659-46D5-810A-8F65E8BD6B5FQ33591202-C197E03F-117D-464E-86D4-67A1E4CD30BFQ33665421-25911134-C920-4287-937B-156B499FE537Q33805704-FFFDBCE4-945A-4B4B-A08C-48D8EC1B4FD1Q33813567-35B38016-6F15-4678-A18C-F6B050C0D041Q33824308-DAB1C907-9DF4-497A-A548-793F4D4FCEC3Q33830151-B81D7CD8-6F3C-493E-9C35-BE3DD4FD3C0EQ33841090-7246A443-0E3F-480A-AB7A-DDBFB4492DAEQ33896372-DB551A40-8DC6-4EC8-80F1-69CDD8B1DDCFQ33960064-AB3E83DD-8C2D-459F-AB9D-7FFE36B8EC56Q33983956-4FB1DA3A-6A64-486A-B2F5-8E33DD63F336Q34070368-BED399B7-5646-43DF-B723-0BE26EB630F9Q34123441-7F3CE7D9-DC25-4F23-87AF-4667EE9B6ACBQ34244713-C37D22D4-B8B6-4656-9C83-270657133B25Q34354817-5A2411CC-3502-4E70-936F-29DE0AF68110Q34494844-B3B9A330-AB3B-4528-9C8D-20C84BEC7A49Q34750485-7C981281-E647-4F2D-A96C-810A8E5D8FB9Q35023593-882332F3-18E2-4E4F-8F87-C9135A320873Q35032747-3B4FC9B6-37F8-4D70-BE86-BD79C3860405Q35095084-C3306C82-B01F-4AFE-A2B1-6B1204B4D934Q35095623-E047B8F7-DBDE-47B4-86C6-E535757A8B05Q35122793-967CBE2D-EF11-4AB4-A5FD-E98A60DA6504Q35614916-B4565B6E-0943-4F2C-A534-D6AEA2D4E084Q35777814-6445A63A-ACB0-4CE3-91E3-2995321D0AB2Q35811216-20357774-89CA-4563-8B4B-0BC9816AF1D1Q35907351-E6989D1F-C528-40C1-AE40-0E6019539366Q36004831-9CFFB70E-5469-4F22-82AC-07FECFD463F4Q36062978-DF03C0D5-839A-4E67-B048-4F351F2316E3Q36107259-A976C1DA-30F6-4080-8812-70AC4CACC4B6
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Copper and iron disorders of the brain.
@ast
Copper and iron disorders of the brain.
@en
type
label
Copper and iron disorders of the brain.
@ast
Copper and iron disorders of the brain.
@en
prefLabel
Copper and iron disorders of the brain.
@ast
Copper and iron disorders of the brain.
@en
P1476
Copper and iron disorders of the brain.
@en
P2093
Erik Madsen
Jonathan D Gitlin
P304
P356
10.1146/ANNUREV.NEURO.30.051606.094232
P577
2007-01-01T00:00:00Z